Avnet to Participate in the Raymond James Institutional Investors Conference on March 4
Avnet to Participate in the Raymond James Institutional Investors Conference on March 4
Avnet (Nasdaq: AVT), a leading global technology solutions provider, today announced it will participate in the upcoming 45th Annual Raymond James Institutional Investors Conference on March 4, 2024.
Avnet’s Chief Financial Officer Ken Jacobson and Vice President, Treasury & Investor Relations Joe Burke will participate in a fireside chat at 11:00 a.m. ET. The live and archived webcast of the presentation can be accessed via Avnet’s Investor Relations web page at https://ir.avnet.com.
About Avnet
As a leading global technology distributor and solutions provider, Avnet has served customers’ evolving needs for more than a century. Decade after decade, Avnet helps its customers and suppliers around the world realize the transformative possibilities of technology. Learn more about Avnet at www.avnet.com. (AVT_IR)
Investor Relations Contact
InvestorRelations@avnet.com
Media Relations Contact
Jeanne Forbis, 480-643-7499
Jeanne.Forbis@avnet.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220968400/en/
-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting